Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: Interaction with drugs acting at 5-HT receptors

Life Sciences

Volumn 75, Issue 20, 2004, Pages 2451-2462

  Peng, Wen Huang ^a   Wu, Chi Rei ^a   Chen, Chia Sheng ^b   Chen, Chung Fung ^a   Leu, Zong Chung ^a   Hsieh, Ming Tsuen ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

5 HT receptors; Anti anxiety; Berberine; Black and white; Elevated plus maze

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANXIOLYTIC AGENT; BERBERINE; BUSPIRONE; DIAZEPAM; MONOAMINE DERIVATIVE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B AGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN STEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; SEROTONINERGIC SYSTEM; STATISTICAL ANALYSIS; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BERBERINE; BUSPIRONE; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; MODELS, THEORETICAL; MOTOR ACTIVITY; RECEPTORS, SEROTONIN; SEROTONIN AGENTS;

EID: 4444364958     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.04.032     Document Type: Article

References (35)

1. M. Atmaca, M. Kuloglu, E. Tezcan, and A. Unal Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings Human Psychopharmacology 17 8 2002 401 405
2. J.G. Barbee Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives Journal of Clinical Psychiatry 54 Suppl. 1993 86 97 discussion 98-101
3. C. Bianchi, A. Siniscalchi, and L. Beani 5-HT1A agonists increase and 5-HT3 agnosts decrease acetylcholine efflux from the cerebral cortex of free-moving guinea-pigs British Journal of Pharmacology 101 2 1990 448 452
4. B.J. Cao, and R.J. Rodgers Anxiolytic-like profile of p-MPPI, a novel 5-HT1A receptor antagonist, in the murine elevated plus-maze Psychopharmacology 129 1997 365 371
5. F. Chaouloff, A. Kulikov, and P. Mormede Reapted DOI and SR46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors European Journal of Pharmacology 334 1 1997 25 29
6. N. Collinson, and G.R. Dawson On the elevated plus-maze the anxiolytic-like effects of the 5-HT1A agonist, 8-OH DPAT, but not the anxiogenic-like effects of the 5-HT1A partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY100635 Psychopharmacology 132 1 1997 35 43
7. M.G. Corda, and G. Biggio Proconflict effect of GABA receptor complex antagonists reversal by diazepam Neuropharmacology 25 1986 541 544
8. B. Costall, and R.J. Naylor Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations British Journal Pharmacology 116 1995 2989 2999
9. B. Costall, C.A. Hendrie, M.E. Kelly, and R.J. Naylor Actions of sulpiride and tiapride in a simple model of anxiety in mice Neuropharmacology 26 1987 195 200
10. J. Crawley, and F.K. Goodwin Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines Pharmacology Biochemistry and Behavior 13 1980 167 170
11. L. De Angelis, and C. Furlan The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test Pharmacology, Biochemistry and Behavior 65 4 2000 649 653
12. C.R. Gardner Recent developments in 5HT-related pharmacology of animal models of anxiety Pharmacology, Biochemistry and Behavior 24 1986 1479 1485
13. M.R. Griebel, M. Saffroy-Spittler, and E. Vogel Anxiolytic and sedative effects of 5-HT1A ligands, 8-OH-DPAT and MDL 73005EF, in mice Neuroreport 1 3-4 1990 267 270
14. G. Griebel, G. Perrault, and D.J. Sanger Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs Psychopharmacologia 131 2 1997 180 186
15. S.L. Handley 5-Hydroxytryptamine pathways in anxiety and its treatment Pharmacological Therapy 66 1 1995 103 148
16. Y. Hong, S.C. Huia, T.Y. Chana, and J. Hou Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy Life Sciences 72 2003 2499 2507
17. C.G. Huang, Z.L. Chu, S.J. Wei, H. Jiang, and B.H. Jiao Effects of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells Thrombosis Research 106 4-5 2002 223 227
18. K.K. Hui, J.L. Yu, W.F. Chan, and E. Tse Interaction of berberine with human platelet alpha 2 adrenoceptors Life Sciences 49 4 1991 315 324
19. L.D. Kong, C.H.K. Cheng, and R.X. Tan Monoamine oxidase inhibitors from Rhizoma of Coptis chinensis Planta Medica 67 2001 74 76
20. M. Koprowska, M. Krotewicz, A. Romaniuk, M. Strzelczuk, and M. Wieczorek Behavioral and neurochemical alterations evoked by p-Chlorophenylalanine application in rats examined in the light-dark crossing test Acta Neurobiological Experiment 59 1 1999 15 22
21. W.H. Lewis, and M.P.F. Elvin-Lewis Internal poisons Medical Botany: Plants affecting man's health 1977 John Wiley New York 11 63
22. M.R. Liebowitz, F. Schneier, R. Campeas, E. Hollander, J. Hatterer, A. Fyer, J. Gorman, L. Papp, S. Davies, R. Gully, and D.F. Klein Phenelzine vs. atenolol in social phobia. A placebo-controlled comparison Archives of General Psychiatry 49 1992 290 300
23. X. Lin, A. Roger, D.V. Jean, and J.R. Michael Effect of repeated ipsapirone treatment on hippocampal excitatory synaptic transmission in the freely 49 behaving rat: role of 5-HT1A receptors and relationship to anxiolytic effect European Journal of Pharmacology 323 1997 59 68
24. P.C. Moser An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone Psychopharmacology 99 1 1989 48 53
25. M. Naoi, and T. Nagatsu Quinoline and quinaldine as a naturally occurring inhibitors specific for type A monoamine oxidase Life Science 40 1986 1075 1082
26. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an EPM as a measure of anxiety in the rat Journal of Neuroscience Methods 14 3 1985 149 167
27. W.H. Peng, M.T. Hsieh, and C.R. Wu Effect of long-term administration of berberine on scopolamine-induced amnesia in rats Japanese Journal of Pharmacology 74 1997 261 266
28. D.S. Pine, G.A. Wasserman, and S.B. Workman Memory and anxiety in prepubertal boys at risk for delinquency Journal of American Academic Child and Adolescent Psychiatry 38 1999 1024 1031
29. B.J. Sadock, and V.A. Sadock Kaplan and Sadock's synopsis of psychiatry-Behavioral sciences/Clinical psychiatry 9th ed. 2003 Lippincott Willams and Wilkins Philadelphia (Chapter 16), Anxiety disorders
30. T. Sharp, S.R. Bramwell, and D.G. Grahame-Smith 5-HT1A agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis British Journal of Pharmacology 96 1989 283 290
31. M.H. Thiebot, P. Soubrie, M. Hamon, and P. Simon Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat Psychopharmacology 82 4 1984 355 359
32. M.H. Thiebot, P. Soubrie, M. Hamon, and P. Simon Evidence against the involvement of serotonergic neurons in the anti-punishment activity of diazepam in the rat Psychopharmacology 82 1984 355 359
33. A.J. Vander, J.H. Sherman, and D.S. Luciano Consciousness and behavior A.J. Vander J.H. Sherman D.S. Luciano Human physiology: The mechanisms of body function 1994 Mc Graw-Hill New York 369 382
34. M. Versiani, A.E. Nardi, F.D. Mundim, A.B. Alves, M.R. Liebowitz, and R. Amrein Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine British Journal of Psychiatry 161 1992 353 360
35. M.P. Viveros, S. Martin, M.J. Ormazabal, M.J. Alfaro, and M.I. Martin Effects of nimodipine and nifedipine upon behavior and regional brain monoamines in the rat Psychopharmacology 127 1996 123 132